ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,196Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 972

$1.38M Total Retail Price of All Prescriptions

Rank: 34 out of 972

600 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 16,314 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 1,407 980 1 1
HYDROCODONE-ACETAMINOPHEN 710 372 S3 2 6
FUROSEMIDE 700 529 3 7
ALLOPURINOL 594 443 4 28
AMLODIPINE BESYLATE 569 438 5 4
GABAPENTIN 542 268 6 14
LEVOTHYROXINE SODIUM 527 409 7 3
METFORMIN HCL 504 327 8 8
OMEPRAZOLE 500 378 9 5
METOPROLOL TARTRATE 450 275 10 9
POTASSIUM CHLORIDE 431 300 11 13
TRAMADOL HCL 411 230 12 15
TRAZODONE HCL 383 221 13 35
DONEPEZIL HCL 375 366 14 26
SIMVASTATIN 356 235 15 2
RANITIDINE HCL 353 188 16 24
PREDNISONE 282 167 17 40
ISOSORBIDE MONONITRATE ER 282 241 17 43
CARVEDILOL 272 186 19 21
FAMOTIDINE 260 155 20 73
HYDRALAZINE HCL 246 189 21 69
WARFARIN SODIUM 240 171 22 12
MIRTAZAPINE 239 207 23 46
SERTRALINE HCL 234 143 24 25
PROAIR HFA 227 89 25 47
CITALOPRAM HBR 225 148 26 19
ZOLPIDEM TARTRATE 191 95 27 23
LOSARTAN POTASSIUM 189 130 28 17
CYMBALTA 189 64 28 49
NAMENDA 186 177 30 38
NEXIUM 181 147 31 30
CARISOPRODOL 180 52 R 32 110
BACLOFEN 173 46 33 123
CLOPIDOGREL 171 145 34 37
PRAVASTATIN SODIUM 168 123 35 20
ESCITALOPRAM OXALATE 166 141 36 65
ATORVASTATIN CALCIUM 164 83 37 11
FLUTICASONE PROPIONATE 163 59 38 31
GLIMEPIRIDE 162 127 39 34
OXYBUTYNIN CHLORIDE 156 93 40 97
LEVETIRACETAM 155 77 41 111
HYDROCHLOROTHIAZIDE 154 103 42 10
SINGULAIR 152 103 43 81
MELOXICAM 152 97 43 36
SPIRONOLACTONE 149 115 45 54
CYCLOBENZAPRINE HCL 147 64 R 46 53
ATENOLOL 143 106 47 18
HALOPERIDOL 137 94 48 168
LANTUS 132 99 49 44
OXYCODONE HCL-ACETAMINOPHEN 127 36 S2 50 106
LOVASTATIN 127 101 50 22
IBUPROFEN 126 35 52 92
TAMSULOSIN HCL 124 91 53 29
JANUVIA 121 94 54 75
ALENDRONATE SODIUM 119 74 55 27
COMBIVENT 119 36 55 94
DIOVAN 119 80 55 48
GLYBURIDE 110 74 R 58 70
OXYBUTYNIN CHLORIDE ER 107 80 59 128
TIZANIDINE HCL 107 31 59 143
POLYETHYLENE GLYCOL 3350 106 50 61 67
PLAVIX 104 92 62 55
TRIAMCINOLONE ACETONIDE 104 64 62 134
QUETIAPINE FUMARATE 102 52 64 83
ESTRADIOL 101 40 R 65 167
RISPERIDONE 101 49 65 76
FINASTERIDE 100 67 67 77
CIPROFLOXACIN HCL 99 57 68 63
ADVAIR DISKUS 98 39 69 45
LIDODERM 95 56 70 115
CEPHALEXIN 95 70 70 124
PANTOPRAZOLE SODIUM 95 65 70 41
FLUOXETINE HCL 90 58 73 60
SPIRIVA 90 63 73 56
INSULIN SYRINGE 89 67 75 84
GLIPIZIDE 88 81 76 59
BYSTOLIC 86 54 77 102
PHENYTOIN SODIUM EXTENDED 84 56 78 140
CELEBREX 84 52 78 85
MONTELUKAST SODIUM 83 59 80 147
OXYCODONE-ACETAMINOPHEN 83 43 S2 80 80
BENICAR 82 62 82 133
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 63 83 109
MECLIZINE HCL 79 48 83 184
ROPINIROLE HCL 78 55 85 72
DIOVAN HCT 78 66 85 122
DIGOXIN 77 75 87 52
METHADONE HCL 77 26 S2 87 251
DIVALPROEX SODIUM 76 37 89 96
EXELON 75 69 90 125
METOCLOPRAMIDE HCL 75 45 90 138
AMITRIPTYLINE HCL 72 22 R 92 58
RAMIPRIL 72 47 92 101
ZETIA 71 21 94 79
AZITHROMYCIN 70 41 95 42
NIFEDIPINE ER 68 62 96 116
FENTANYL 68 43 S2 96 89
NYSTATIN 67 37 98 156
GLIPIZIDE XL 66 55 99 198
NASONEX 66 28 99 205
PEN NEEDLE 65 50 101 99
CLOTRIMAZOLE-BETAMETHASONE 64 38 102 199
DICLOFENAC SODIUM 64 41 102 130
CARBIDOPA-LEVODOPA 64 63 102 87
DILTIAZEM 24HR CD 64 64 102 74
ENABLEX 63 24 106 204
NAPROXEN 62 23 107 71
LANTUS SOLOSTAR 61 50 108 86
PROCHLORPERAZINE MALEATE 57 22 109 250
METOPROLOL SUCCINATE 56 35 110 16
LIPITOR 55 30 111 90
LEVOFLOXACIN 54 39 112 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 45 112 32
NITROFURANTOIN MONO-MACRO 51 43 114 254
ACTOS 51 44 114 163
PAROXETINE HCL 50 14 116 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.